MSD Carlow is a state-of-the-art, 200,000 sq ft vaccines and biologics facility focused on formulating and filling vaccine and biologic products that improve and transform the lives of people across the world. We are growing our highly-skilled team and building our presence in Carlow so that we can continue to lead scientific breakthroughs in the treatment of some of the world’s most harmful diseases.
If you want to belong to a team that makes a difference and are committed to inventing for life, MSD Carlow, Ireland, would like to hear from you.
MSD in Carlow is a world-class manufacturing facility, and the company’s first stand-alone vaccine and biologics facility outside the US. Carlow employs over 400 highly skilled employees and is an important element of MSD’s network of sites, playing a pivotal role in the manufacture of our immuno-oncology treatment.
In October 2018 MSD announced the expansion of its Carlow site with the construction of a new facility. The new facility will focus on the production of vaccines and biologics and there will also be an expansion of warehouse and laboratory services at the site. Recruitment for the new facility will commence immediately and it is intended that the new manufacturing operations will commence in 2023.
MSD’s sustained investment in Ireland empowers Carlow to offer its team the opportunity to continuously grow, learn, invent and thrive. We aim to attract driven individuals who share our ambition to impact tomorrow, today by responding to the world’s most vital, unmet health needs.